An injection device
By setting pressure and impedance sensors on the microneedles, the resistance and electrical impedance of the microneedles can be detected in real time, solving the problem of position determination during microneedle puncture and improving the accuracy and safety of minimally invasive drug delivery.
Patent Information
- Application Number
- CN202522512452.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2025-11-26
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2035-11-26
AI Technical Summary
In existing technologies, medical staff have difficulty determining the real-time position of the microneedle during the puncture process, resulting in insufficient accuracy and safety of minimally invasive drug delivery.
A pressure sensor is connected to the microneedle, and resistance detection is used. Combined with an impedance sensor placed at the connection between the microneedle and the connector, the position of the microneedle can be determined in real time by detecting the resistance during the microneedle puncture process and the electrical impedance of the biological tissue.
It enables precise location determination during the microneedle puncture process, improves the accuracy and safety of minimally invasive drug delivery, and ensures that the drug accurately reaches the injection area.
Smart Images

Figure CN224975126U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical device technology, and more specifically, to an injection device. Background Technology
[0002] With the increasing demand for ophthalmic disease treatment, drug delivery technology for posterior segment eye diseases has become an important research direction in clinical treatment. Among them, microneedle drug delivery systems have become a research hotspot in the treatment of posterior segment eye diseases due to their minimally invasive characteristics. This technology uses miniaturized needle-like structures to deliver drugs to specific areas within the eye (such as the vitreous cavity or subretinal space).
[0003] However, with existing technology, it is difficult for medical staff to determine the real-time position of the microneedle during the puncture process. Utility Model Content
[0004] The purpose of this invention is to provide an injection device that can detect the resistance experienced by the microneedle and the electrical impedance of the biological tissue in which it is located, thereby using the resistance and electrical impedance to determine the real-time position of the microneedle during the puncture process.
[0005] The embodiments of this utility model can be implemented as follows: In a first aspect, this utility model provides an injection device, comprising: An injection unit, comprising a base, a connector, and a microneedle connected in sequence; The monitoring unit includes a pressure sensor and an impedance sensor. The pressure sensor is connected to the microneedle and is used to detect the resistance encountered by the tip of the microneedle during puncture. The impedance sensor is located at the connection between the microneedle and the connector and is used to detect the electrical impedance of the biological tissue where the tip of the microneedle is located.
[0006] In an alternative implementation, the pressure sensor is positioned at the tip of the microneedle.
[0007] In an optional embodiment, the impedance sensor includes a first electrode and a second electrode, with the metal wall at the tail end of the microneedle forming the first electrode and the second electrode disposed within the connector.
[0008] In an optional implementation, the monitoring unit further includes a wire and an insulating layer, one end of which is electrically connected to the pressure sensor and the other end extends to a connector; The insulation layer is wrapped around the wire and attached to the periphery of the microneedle.
[0009] In an optional implementation, the outer diameter of the wire ranges from 15 μm to 30 μm.
[0010] In an optional implementation, the microneedle includes a straight needle and a curved needle, both of which are connected to a connector. The tip of the straight needle is equipped with a pressure sensor, and the connection between the straight needle and the connector is equipped with an impedance sensor. The tip of the bent needle is equipped with a pressure sensor, and the connection between the bent needle and the connector is equipped with an impedance sensor.
[0011] In an optional embodiment, the connector is provided with a first telescopic member and a second telescopic member. The first telescopic member is connected to a straight needle and is used to drive the straight needle to extend or retract along its axial direction. The second telescopic member is connected to a curved needle and is used to drive the curved needle to extend or retract along its bending trajectory.
[0012] In an optional embodiment, the length of the straight needle ranges from 1 mm to 6 mm; the inner diameter of the straight needle ranges from 20 μm to 60 μm.
[0013] In an optional embodiment, the length of the bent needle ranges from 1 mm to 6 mm; the inner diameter of the bent needle ranges from 20 μm to 60 μm; and the radius of curvature of the bent needle ranges from 8 mm to 15 mm.
[0014] In an optional embodiment, the injection unit further includes a quick connector that connects to the base and the connector.
[0015] The beneficial effects of the injection device provided in this embodiment of the present invention include: In this embodiment, a pressure sensor is connected to the microneedle, and an impedance sensor is set at the connection between the microneedle and the connector. By using the resistance encountered by the microneedle during the puncture process detected by the pressure sensor and the electrical impedance of the biological tissue where the microneedle is located detected by the impedance sensor, the real-time position of the microneedle during the puncture process can be determined. This makes it easier for medical staff to determine whether the microneedle has penetrated the target barrier and reached the injection area, thereby achieving precise drug delivery and improving accuracy and safety. Attached Figure Description
[0016] To more clearly illustrate the technical solutions of the embodiments of this utility model, the drawings used in the embodiments will be briefly introduced below. It should be understood that the following drawings only show some embodiments of this utility model and should not be regarded as a limitation on the scope. For those skilled in the art, other related drawings can be obtained based on these drawings without creative effort.
[0017] Figure 1 This is a schematic diagram of the injection unit provided in this embodiment; Figure 2 This is a partial schematic diagram of the injection device provided in this embodiment.
[0018] Icons: 100-Monitoring unit; 110-Pressure sensor; 120-Impedance sensor; 200-Injection unit; 210-Microneedle; 211-Straight needle; 212-Bent needle; 220-Connector; 230-Base. Detailed Implementation
[0019] To make the objectives, technical solutions, and advantages of the embodiments of this utility model clearer, the technical solutions of the embodiments of this utility model will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this utility model, and not all embodiments. The components of the embodiments of this utility model described and shown in the accompanying drawings can generally be arranged and designed in various different configurations.
[0020] Therefore, the following detailed description of the embodiments of the present invention provided in the accompanying drawings is not intended to limit the scope of the claimed invention, but merely to illustrate selected embodiments of the invention. All other embodiments obtained by those skilled in the art based on the embodiments of the present invention without inventive effort are within the scope of protection of the present invention.
[0021] It should be noted that similar labels and letters in the following figures indicate similar items. Therefore, once an item is defined in one figure, it does not need to be further defined and explained in subsequent figures.
[0022] In the description of this utility model, it should be noted that if terms such as "upper," "lower," "inner," or "outer" are used to indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings, or the orientation or positional relationship in which the utility model product is usually placed during use, they are only for the convenience of describing this utility model and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of this utility model.
[0023] Furthermore, the terms "first" and "second" are used only to distinguish descriptions and should not be interpreted as indicating or implying relative importance.
[0024] It should be noted that, where there is no conflict, the features in the embodiments of this utility model can be combined with each other.
[0025] Please refer to Figure 1 and Figure 2 This utility model provides an injection device for minimally invasive drug delivery, which is particularly suitable for precise drug delivery to specific intraocular areas such as the vitreous cavity or subretinal space in the field of ophthalmology.
[0026] The injection device includes an injection unit 200 and a monitoring unit 100. The injection unit 200 includes a base 230, a connector 220, and a microneedle 210 connected in sequence. The monitoring unit 100 includes a pressure sensor 110 and an impedance sensor 120. The pressure sensor 110 is connected to the microneedle 210 and is used to detect the resistance encountered by the tip of the microneedle 210 during puncture. The impedance sensor 120 is disposed at the connection between the microneedle 210 and the connector 220 and is used to detect the electrical impedance of the biological tissue where the tip of the microneedle 210 is located.
[0027] The base 230, connector 220, and microneedle 210 are connected sequentially along the axial direction. Understandably, the base 230 is used for fixed connection with an external drive device or handheld operating device, and the connector 220 serves as a transition support. The microneedle 210 is a miniature needle body made of metal, with a sharp structure at the end furthest from the connector 220.
[0028] It should be noted that during the microneedle 210 puncture process, physical barriers such as the sclera within the eye can obstruct the microneedle 210. Therefore, the microneedle 210 encounters resistance as it passes through these physical barriers. The pressure sensor 110 detects this resistance, allowing medical personnel to determine if the microneedle 210 has passed through a physical barrier. Since the resistance primarily acts on the tip of the microneedle 210, the pressure sensor 110 is positioned at the tip to ensure more accurate detection of the resistance.
[0029] Since different biological tissues in the eye have different electrical impedances, this embodiment distinguishes which tissue layer the tip of the microneedle 210 is located by setting an impedance sensor 120 and detecting the electrical impedance value at the location of the microneedle 210 tip.
[0030] For example, the sclera is rich in collagen fibers, has low conductivity, and exhibits high impedance; the choroid contains abundant blood vessels and pigment cells, its impedance is relatively low, and it has specific frequency response characteristics; the retina is neural tissue with densely packed cells and high membrane resistance, exhibiting a high impedance value under low-frequency AC signals; the vitreous cavity is filled with a transparent gel-like fluid with a high electrolyte content, good conductivity, and the lowest impedance. Therefore, when the microneedle 210 passes through these tissues sequentially, the impedance value measured by the impedance sensor 120 will show a regular change.
[0031] Connector 220 contains a signal transmitter. Understandably, when pressure sensor 110 detects resistance, it generates a resistance signal and transmits it to the signal transmitter. Similarly, when impedance sensor 120 detects impedance, it generates an impedance signal and transmits it to the signal transmitter. The signal transmitter receives both signals and transmits them to an external computer. The computer combines the trend of impedance changes with the information fed back by the resistance signal (such as a brief resistance peak when passing through the sclera and a sharp drop in resistance after entering the vitreous humor) to determine the position of the microneedle 210. This allows the computer to determine whether the microneedle 210 has penetrated the target barrier and reached the injection area, and to promptly send feedback signals to medical personnel.
[0032] Based on the above, the monitoring unit 100 also includes a wire and an insulating layer. One end of the wire is electrically connected to the pressure sensor 110, and the other end extends to the connector 220. The insulating layer wraps around the wire and is attached to the peripheral wall of the microneedle 210. Specifically, the other end of the wire extends into the connector 220 and is electrically connected to a signal transmitter located inside the device, thereby transmitting resistance signals using the wire. The insulating layer wraps around the wire, forming an electrical isolation barrier to prevent short circuits between the wire and the microneedle 210.
[0033] It should be noted that in this embodiment, the outer diameter of the wire ranges from 15μm to 30μm.
[0034] Furthermore, the impedance sensor 120 includes a first electrode and a second electrode, with the metal wall at the tail end of the microneedle 210 forming the first electrode and the second electrode disposed within the connector 220.
[0035] Because the microneedle 210 is made of a metallic material, it is conductive, eliminating the need for additional independent electrode components and simplifying the device.
[0036] The second electrode is located inside the connector 220, typically employing a metal thin film or ring-shaped electrode structure. It is fixed at the interface where it mates with the microneedle 210, maintaining electrical insulation from the microneedle 210 body while being spatially adjacent to it. When the microneedle 210 is inserted into biological tissue, a low-amplitude AC signal is applied using the first electrode as the excitation electrode, and the second electrode as the detection electrode. By measuring the impedance response between the two electrodes, the electrical impedance characteristics of the local tissue at the tip of the microneedle 210 are obtained.
[0037] Since the sensing area of the impedance sensor 120 is mainly concentrated around the distal puncture path of the microneedle 210, and the current conduction path exhibits specific impedance spectrum characteristics due to the influence of different tissue dielectric properties, different intraocular tissues can be distinguished based on the measured impedance amplitude and phase change.
[0038] Furthermore, the microneedle 210 includes a straight needle 211 and a curved needle 212, both of which are connected to the connector 220; the tip of the straight needle 211 is equipped with a pressure sensor 110, and the connection between the straight needle 211 and the connector 220 is equipped with an impedance sensor 120; the tip of the curved needle 212 is equipped with a pressure sensor 110, and the connection between the curved needle 212 and the connector 220 is equipped with an impedance sensor 120.
[0039] This embodiment uses a straight needle 211 and a curved needle 212 to form a multi-channel composite injection structure, which allows medical staff to choose different puncture paths and drug delivery methods according to the actual situation.
[0040] In order to monitor the real-time position of the straight needle 211 and the curved needle 212 during the puncture process, both the straight needle 211 and the curved needle 212 are equipped with independent pressure sensors 110 and impedance sensors 120.
[0041] In addition, the connector 220 is provided with a first telescopic member and a second telescopic member. The first telescopic member is connected to the straight needle 211 and is used to drive the straight needle 211 to extend or retract along its axial direction. The second telescopic member is connected to the bent needle 212 and is used to drive the bent needle 212 to extend or retract along its bending trajectory.
[0042] The telescopic component can be a push rod structure driven by a micro motor. The first telescopic component and the second telescopic component drive the straight needle 211 and the curved needle 212 to move, respectively. When it is necessary to administer medication using the straight needle 211, the first telescopic component pushes the straight needle 211 to extend axially; when it is necessary to administer medication using the curved needle 212, the second telescopic component pushes the curved needle 212 to extend along its curved trajectory.
[0043] If it is necessary to administer medication first using the straight needle 211 and then using the curved needle 212, the first telescopic member pushes the straight needle 211 to extend axially. After the straight needle 211 reaches the injection area and completes the medication administration, the first telescopic member then drives the straight needle 211 to retract. Next, the second telescopic member pushes the curved needle 212 to extend along its curved trajectory. After the curved needle 212 reaches the injection area and completes the medication administration, the second telescopic member then drives the curved needle 212 to retract.
[0044] It should be noted that the connector 220 is provided with a needle chamber for accommodating straight needles 211 and bent needles 212.
[0045] In this embodiment, the length of the straight needle 211 ranges from 1 mm to 6 mm; the inner diameter of the straight needle 211 ranges from 20 μm to 60 μm. The length of the curved needle 212 ranges from 1 mm to 6 mm; the inner diameter of the curved needle 212 ranges from 20 μm to 60 μm; the radius of curvature of the curved needle 212 ranges from 8 mm to 15 mm.
[0046] Furthermore, the injection unit 200 also includes a quick connector that connects to the base 230 and the connector 220, allowing medical personnel to quickly detach the connector 220 and the microneedle 210 after injection, thereby improving efficiency.
[0047] In summary, this embodiment connects a pressure sensor 110 to the microneedle 210 and sets an impedance sensor 120 at the connection between the microneedle 210 and the connector 220. By using the resistance encountered by the microneedle 210 during the puncture process detected by the pressure sensor 110 and the electrical impedance of the biological tissue where the microneedle 210 is located detected by the impedance sensor 120, the real-time position of the microneedle 210 during the puncture process can be determined. This makes it easier for medical personnel to determine whether the microneedle 210 has penetrated the target barrier and reached the injection area, thereby achieving precise drug delivery and improving accuracy and safety.
[0048] The above description is only a specific embodiment of this utility model, but the protection scope of this utility model is not limited thereto. Any changes or substitutions that can be easily conceived by those skilled in the art within the technical scope disclosed in this utility model should be included within the protection scope of this utility model.
Claims
1. An injection device, characterized in that, include: The injection unit (200) includes a base (230), a connector (220), and a microneedle (210) connected in sequence. The monitoring unit (100) includes a pressure sensor (110) and an impedance sensor (120). The pressure sensor (110) is connected to the microneedle (210) and is used to detect the resistance encountered by the microneedle (210) during puncture. The impedance sensor (120) is located at the connection between the microneedle (210) and the connector (220) and is used to detect the electrical impedance of the biological tissue where the microneedle (210) is located.
2. The injection device according to claim 1, characterized in that, The pressure sensor (110) is disposed at the tip of the microneedle (210).
3. The injection device according to claim 2, characterized in that, The impedance sensor (120) includes a first electrode and a second electrode. The first electrode is formed by the metal wall at the tail end of the microneedle (210), and the second electrode is disposed in the connector (220).
4. The injection device according to claim 2, characterized in that, The monitoring unit (100) also includes a wire and an insulating layer, one end of which is electrically connected to the pressure sensor (110) and the other end extends to the connector (220). The insulating layer is wrapped around the wire and attached to the periphery of the microneedle (210).
5. The injection device according to claim 4, characterized in that, The outer diameter of the conductor is in the range of 15μm - 30μm.
6. The injection device according to claim 1, characterized in that, The microneedle (210) includes a straight needle (211) and a curved needle (212), both of which are connected to a connector (220). The pressure sensor (110) is disposed at the tip of the straight needle (211), and the impedance sensor (120) is disposed at the connection between the straight needle (211) and the connector (220). The pressure sensor (110) is disposed at the tip of the bent needle (212), and the impedance sensor (120) is disposed at the connection between the bent needle (212) and the connector (220).
7. The injection device according to claim 6, characterized in that, The connector (220) is provided with a first telescopic member and a second telescopic member. The first telescopic member is connected to the straight needle (211) and is used to drive the straight needle (211) to extend or retract along its axial direction. The second telescopic member is connected to the curved needle (212) and is used to drive the curved needle (212) to extend or retract along its bending trajectory.
8. The injection device according to claim 6, characterized in that, The length of the straight needle (211) ranges from 1 mm to 6 mm; the inner diameter of the straight needle (211) ranges from 20 μm to 60 μm.
9. The injection device according to claim 6, characterized in that, The length of the bent needle (212) ranges from 1 mm to 6 mm; the inner diameter of the bent needle (212) ranges from 20 μm to 60 μm; and the radius of curvature of the bent needle (212) ranges from 8 mm to 15 mm.
10. The injection device according to claim 1, characterized in that, The injection unit (200) also includes a quick connector that is connected to the base (230) and the connector (220).
